
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain activ... Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.135 | 52.1235521236 | 0.259 | 0.475 | 0.2417 | 21205212 | 0.35835961 | CS |
4 | 0.1319 | 50.3243037009 | 0.2621 | 0.475 | 0.24 | 5721177 | 0.35610783 | CS |
12 | -0.138 | -25.9398496241 | 0.532 | 0.7999 | 0.24 | 2327410 | 0.3727067 | CS |
26 | -0.376 | -48.8311688312 | 0.77 | 1.1099 | 0.24 | 1221443 | 0.44166643 | CS |
52 | -0.736 | -65.1327433628 | 1.13 | 1.87 | 0.24 | 609699 | 0.45023396 | CS |
156 | -3.046 | -88.5465116279 | 3.44 | 4.2 | 0.24 | 216594 | 0.591527 | CS |
260 | -14.566 | -97.3663101604 | 14.96 | 19.56 | 0.24 | 439676 | 7.90683319 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관